WO2001024830A3 - Incorporation of chemical substances into cells - Google Patents
Incorporation of chemical substances into cells Download PDFInfo
- Publication number
- WO2001024830A3 WO2001024830A3 PCT/US2000/027562 US0027562W WO0124830A3 WO 2001024830 A3 WO2001024830 A3 WO 2001024830A3 US 0027562 W US0027562 W US 0027562W WO 0124830 A3 WO0124830 A3 WO 0124830A3
- Authority
- WO
- WIPO (PCT)
- Prior art keywords
- cells
- incorporation
- chemical substances
- methods
- compositions
- Prior art date
Links
- 239000000126 substance Substances 0.000 title abstract 3
- 238000010348 incorporation Methods 0.000 title abstract 2
- 238000000034 method Methods 0.000 abstract 3
- 239000000203 mixture Substances 0.000 abstract 3
- QVGXLLKOCUKJST-UHFFFAOYSA-N atomic oxygen Chemical compound [O] QVGXLLKOCUKJST-UHFFFAOYSA-N 0.000 abstract 2
- 210000003743 erythrocyte Anatomy 0.000 abstract 2
- 229910052760 oxygen Inorganic materials 0.000 abstract 2
- 239000001301 oxygen Substances 0.000 abstract 2
- 108010054147 Hemoglobins Proteins 0.000 abstract 1
- 102000001554 Hemoglobins Human genes 0.000 abstract 1
- 108010015562 acetylated hemoglobin Proteins 0.000 abstract 1
- 239000012637 allosteric effector Substances 0.000 abstract 1
- 210000004027 cell Anatomy 0.000 abstract 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07F—ACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
- C07F9/00—Compounds containing elements of Groups 5 or 15 of the Periodic Table
- C07F9/02—Phosphorus compounds
- C07F9/28—Phosphorus compounds with one or more P—C bonds
- C07F9/38—Phosphonic acids [RP(=O)(OH)2]; Thiophosphonic acids ; [RP(=X1)(X2H)2(X1, X2 are each independently O, S or Se)]
- C07F9/40—Esters thereof
- C07F9/4003—Esters thereof the acid moiety containing a substituent or a structure which is considered as characteristic
- C07F9/4018—Esters of cycloaliphatic acids
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07F—ACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
- C07F9/00—Compounds containing elements of Groups 5 or 15 of the Periodic Table
- C07F9/02—Phosphorus compounds
- C07F9/06—Phosphorus compounds without P—C bonds
- C07F9/08—Esters of oxyacids of phosphorus
- C07F9/09—Esters of phosphoric acids
- C07F9/117—Esters of phosphoric acids with cycloaliphatic alcohols
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Biochemistry (AREA)
- General Health & Medical Sciences (AREA)
- Molecular Biology (AREA)
- Medicines Containing Material From Animals Or Micro-Organisms (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Abstract
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
AU79956/00A AU7995600A (en) | 1999-10-05 | 2000-10-05 | Compositions and methods for the incorporation of chemical substances into cells |
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US15773599P | 1999-10-05 | 1999-10-05 | |
US60/157,735 | 1999-10-05 |
Publications (2)
Publication Number | Publication Date |
---|---|
WO2001024830A2 WO2001024830A2 (en) | 2001-04-12 |
WO2001024830A3 true WO2001024830A3 (en) | 2002-03-14 |
Family
ID=22565043
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
PCT/US2000/027562 WO2001024830A2 (en) | 1999-10-05 | 2000-10-05 | Incorporation of chemical substances into cells |
Country Status (2)
Country | Link |
---|---|
AU (1) | AU7995600A (en) |
WO (1) | WO2001024830A2 (en) |
Cited By (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US9546350B2 (en) | 2004-05-12 | 2017-01-17 | Maxcyte, Inc. | Methods and devices related to a regulated flow electroporation chamber |
Families Citing this family (7)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US6773669B1 (en) | 1995-03-10 | 2004-08-10 | Maxcyte, Inc. | Flow electroporation chamber and method |
AU2001279118A1 (en) | 2000-08-01 | 2002-02-13 | Gmp Companies, Inc. | Ammonium salts of inositol hexaphosphate and uses thereof |
US7029916B2 (en) | 2001-02-21 | 2006-04-18 | Maxcyte, Inc. | Apparatus and method for flow electroporation of biological samples |
EP2574662B1 (en) | 2001-08-22 | 2021-08-04 | Maxcyte, Inc. | Method for electroporation of biological samples |
US7084115B2 (en) | 2002-04-29 | 2006-08-01 | Oxyplus, Inc. | Inositol pyrophosphates, and methods of use thereof |
US7745423B2 (en) | 2004-07-06 | 2010-06-29 | NormOxys, Inc | Calcium/sodium salt of inositol tripyrophosphate as an allosteric effector of hemoglobin |
MX2021008966A (en) * | 2019-01-30 | 2021-11-04 | Sanifit Therapeutics S A | Inositol phosphate compounds for use in increasing tissular perfusion. |
Citations (4)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
EP0472772A1 (en) * | 1989-08-03 | 1992-03-04 | Krüss GmbH | Process for the preparation of vital drug-laden human erythrocytes |
WO1994021117A1 (en) * | 1993-03-23 | 1994-09-29 | Cbr Laboratories, Inc. | Method and apparatus for encapsulation of biologically-active substances in cells |
WO1996028199A1 (en) * | 1995-03-10 | 1996-09-19 | Entremed, Inc. | Flow electroporation chamber and method |
US20010001064A1 (en) * | 1998-03-18 | 2001-05-10 | Holaday John W. | Flow electroporation chamber and methods of use thereof |
-
2000
- 2000-10-05 AU AU79956/00A patent/AU7995600A/en not_active Abandoned
- 2000-10-05 WO PCT/US2000/027562 patent/WO2001024830A2/en active Application Filing
Patent Citations (4)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
EP0472772A1 (en) * | 1989-08-03 | 1992-03-04 | Krüss GmbH | Process for the preparation of vital drug-laden human erythrocytes |
WO1994021117A1 (en) * | 1993-03-23 | 1994-09-29 | Cbr Laboratories, Inc. | Method and apparatus for encapsulation of biologically-active substances in cells |
WO1996028199A1 (en) * | 1995-03-10 | 1996-09-19 | Entremed, Inc. | Flow electroporation chamber and method |
US20010001064A1 (en) * | 1998-03-18 | 2001-05-10 | Holaday John W. | Flow electroporation chamber and methods of use thereof |
Non-Patent Citations (1)
Title |
---|
EINCK, L. ET AL: "Enhancement of tissue oxygenation by intracellular introduction of inositol hexaphosphate by flow electroporation of red blood cells", UPDATE INTENSIVE CARE EMERG. MED. (1998), 33(TISSUE OXYGENATION IN ACUTE MEDICINE), 357-374, XP001023862 * |
Cited By (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US9546350B2 (en) | 2004-05-12 | 2017-01-17 | Maxcyte, Inc. | Methods and devices related to a regulated flow electroporation chamber |
Also Published As
Publication number | Publication date |
---|---|
AU7995600A (en) | 2001-05-10 |
WO2001024830A2 (en) | 2001-04-12 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
Rucker et al. | Physiological importance of pyrroloquinoline quinone | |
EP1484339A3 (en) | Kallikrein-inhibiting "Kunitz Domain" proteins and nucleic acids encoding the same | |
WO2002057413A3 (en) | Peptides for activation and inhibition of delta pkc | |
EP1466968A3 (en) | Method and apparatus for encapsulation of biologically-active substances | |
FR2791684B1 (en) | COSMETIC OR DERMOPHARMACEUTICAL COMPOSITION CONTAINING THE TRIPEPTIDE N-N-BIOTINYL-GLY-HIS-LYS FOR PREVENTING, REDUCING OR SUPPRESSING HAIR LOSS AS WELL AS TO PROMOTE THEIR GROWTH | |
CA2303498A1 (en) | Dioxocyclopentyl hydroxamic acids | |
WO2003072734A3 (en) | Bipolar trans carotenoid salts and their uses | |
AU2002329951A1 (en) | Fixed-dried red blood cells | |
WO2001024830A3 (en) | Incorporation of chemical substances into cells | |
DE60028152D1 (en) | Solid, stable and concentrated biologically digestible complex of orthosilicic acid and process for its preparation | |
WO2020045718A1 (en) | Aptamer specifically binding to l-ascorbic acid and use thereof | |
WO2001098235A3 (en) | 3,4-dihydroxybenzyl-substituted carbonic acid derivatives and the use thereof as antioxidants | |
WO2005030040A3 (en) | Hematopoietic stem cell identification and isolation | |
JP2001525373A5 (en) | ||
WO2005051978A3 (en) | Compounds for delivering amino acids or peptides with antioxidant activity into mitochondria and use thereof | |
AU4431599A (en) | Organosilicone compositions for personal care | |
WO2001036465A3 (en) | Human zven proteins | |
AU2002362060A1 (en) | Preparation of red blood cells having reduced immunogenicity | |
EA200600468A1 (en) | BIPOLAR TRANS-CAROTINOID SALTS AND THEIR APPLICATION | |
WO2002072059A3 (en) | Topical composition comprising a functionally alkylating cosmetic bonding agent | |
EP1211311A3 (en) | Cord blood-derived activated lymphocytes and preparations containing said lymphocytes | |
AU2002238218A1 (en) | Prolonged storage of red blood cells | |
WO2002072057A3 (en) | Topical composition comprising a functionally acylating cosmetic bonding agent | |
AU3460800A (en) | Method of bleaching blood samples, diagnostic method and diagnostic kit using the same | |
WO2001051489A3 (en) | Methods for lowering uric acid levels |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
AK | Designated states |
Kind code of ref document: A2 Designated state(s): AE AG AL AM AT AU AZ BA BB BG BR BY BZ CA CH CN CR CU CZ DE DK DM DZ EE ES FI GB GD GE GH GM HR HU ID IL IN IS JP KE KG KP KR KZ LC LK LR LS LT LU LV MA MD MG MK MN MW MX MZ NO NZ PL PT RO RU SD SE SG SI SK SL TJ TM TR TT TZ UA UG US UZ VN YU ZA ZW |
|
AL | Designated countries for regional patents |
Kind code of ref document: A2 Designated state(s): GH GM KE LS MW MZ SD SL SZ TZ UG ZW AM AZ BY KG KZ MD RU TJ TM AT BE CH CY DE DK ES FI FR GB GR IE IT LU MC NL PT SE BF BJ CF CG CI CM GA GN GW ML MR NE SN TD TG |
|
121 | Ep: the epo has been informed by wipo that ep was designated in this application | ||
DFPE | Request for preliminary examination filed prior to expiration of 19th month from priority date (pct application filed before 20040101) | ||
AK | Designated states |
Kind code of ref document: A3 Designated state(s): AE AG AL AM AT AU AZ BA BB BG BR BY BZ CA CH CN CR CU CZ DE DK DM DZ EE ES FI GB GD GE GH GM HR HU ID IL IN IS JP KE KG KP KR KZ LC LK LR LS LT LU LV MA MD MG MK MN MW MX MZ NO NZ PL PT RO RU SD SE SG SI SK SL TJ TM TR TT TZ UA UG US UZ VN YU ZA ZW |
|
AL | Designated countries for regional patents |
Kind code of ref document: A3 Designated state(s): GH GM KE LS MW MZ SD SL SZ TZ UG ZW AM AZ BY KG KZ MD RU TJ TM AT BE CH CY DE DK ES FI FR GB GR IE IT LU MC NL PT SE BF BJ CF CG CI CM GA GN GW ML MR NE SN TD TG |
|
WWE | Wipo information: entry into national phase |
Ref document number: 10110060 Country of ref document: US |
|
REG | Reference to national code |
Ref country code: DE Ref legal event code: 8642 |
|
122 | Ep: pct application non-entry in european phase | ||
NENP | Non-entry into the national phase |
Ref country code: JP |